Latest news with #IanTurner
Yahoo
3 days ago
- Business
- Yahoo
Independent Non-Executive Director of Radiopharm Theranostics Picks Up 48% More Stock
Even if it's not a huge purchase, we think it was good to see that Ian Turner, the Independent Non-Executive Director of Radiopharm Theranostics Limited (ASX:RAD) recently shelled out AU$87k to buy stock, at AU$0.029 per share. That purchase might not be huge but it did increase their holding by 48%. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. The MD, CEO & Director Riccardo Canevari made the biggest insider purchase in the last 12 months. That single transaction was for AU$241k worth of shares at a price of AU$0.031 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being AU$0.024). It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. In the last twelve months insiders purchased 22.43m shares for AU$772k. But insiders sold 1.50m shares worth AU$43k. Overall, Radiopharm Theranostics insiders were net buyers during the last year. Their average price was about AU$0.034. These transactions suggest that insiders have considered the current price attractive. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! Check out our latest analysis for Radiopharm Theranostics Radiopharm Theranostics is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket. Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. From our data, it seems that Radiopharm Theranostics insiders own 11% of the company, worth about AU$6.3m. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing! It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Radiopharm Theranostics insiders are expecting a bright future. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. When we did our research, we found 4 warning signs for Radiopharm Theranostics (2 make us uncomfortable!) that we believe deserve your full attention. But note: Radiopharm Theranostics may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The Australian
30-04-2025
- Business
- The Australian
Tariff turmoil may not be as bad for M&A as it seems
It is often said that the one thing markets hate the most is uncertainty. Broadly, that is true: global equity markets' negative reactions to the US's 'Liberation Day' tariff regime are attributable not just to their perceived economic cost, but also to uncertainties regarding the policy's implementation and duration. It follows that M&A activity in Australia and globally will be impacted as deal-makers wait to see what happens. But CFOs shouldn't assume that deal activity will fall off completely. Prior to the Liberation Day announcement, the M&A market was regaining global momentum after a post-pandemic slump. Despite the significant disruption the tariffs will cause, a number of these factors remain in play. Insolvencies and distressed sales may remain high Although the permanency and exact scope of the tariff regime is uncertain, it will necessarily disrupt global trade and cause distress to businesses across the world. This comes on top of many years of mounting insolvency and bankruptcy figures both in the US and Australia. In both jurisdictions, company insolvencies have been caused by higher interest rates and low consumer sentiment in the post-Covid inflationary period, which has only just retreated. In Australia, these market dynamics have also seen increased use of the small business restructuring regime and the use of distressed debt specialists and safe harbour provisions for larger entities, which are alternatives to traditional insolvency processes. Sector-wise we have seen signs of stress in aspects of the health industry – such as privately run hospitals and aged care facilities, alongside mining, property and construction, retail and agriculture. These sectors are all vulnerable to a general global economic slowdown which the tariffs are predicted to cause. Australian miners will be particularly impacted by a global commodities rout if the US proceeds with placing tariffs in excess of 100 per cent on Chinese exports. Ian Turner is Strategy, Risk & Transactions Managing Partner at Deloitte Australia From an M&A perspective, an increase in distressed businesses could represent a value play for astute buyers with a long-term view and a cash reserve on the balance sheet. Meanwhile, the current uncertainty around US trade policy may increase the impetus for industry consolidation in many areas, with one-time competitors joining forces to create larger, more resilient businesses that can more readily ride out the geopolitical storm. New pools of credit emerging Private credit markets expanded rapidly across the world following tighter capital standards and lending rules put in place in the wake of the Global Financial Crisis and are worth around $US2 trillion ($3.14 trillion) today. In Australia, private credit, although still a small percentage of the credit system, has grown at a faster rate than total business debt for a number of years. While private credit lenders are no doubt pausing to assess the situation, they may eventually find Australia an even more attractive investment destination if the US ultimately proceeds with imposing tariffs above the 10 per cent baseline on other countries. Meanwhile, the weakening of our dollar following falling commodity prices will make the price of acquisitions here relatively more affordable for foreign private credit players. Outside of private credit, debt is likely to become cheaper in Australia and globally. Markets now expect central banks everywhere to bring forward interest rate cuts, and some commentators have even speculated over a return to quantitative easing, which would add significant liquidity to global markets. IPO market — keep your powder dry a moment longer Last year saw Australia's IPO activity return to form after a few slow years post-pandemic. IPO activity on the Australian Securities Exchange in 2024 saw $4.1bn across 67 listings, a nearly three-fold increase from 2023. Prior to the recent tariff curveball, there was significant positive sentiment around the outlook for IPO activity in 2025, with public market investors willing to deploy capital for quality assets. It is likely that uncertainty over the global economy will cause this nascent momentum to stall — but that doesn't mean best-laid plans should go to waste. Management teams considering an IPO should, therefore, do all they can to get ready for their next best opportunity, when uncertainty recedes below their risk threshold. Key to this is establishing strong and accurate internal forecasting and carefully evaluating which key performance indicators (KPIs) and non-IFRS metrics are most relevant, to develop a clear and concise equity story for the market. Regardless of the global economic environment, growing regulatory and economic scrutiny, along with increasingly shortened timelines for going public, means it is more crucial than ever to prioritise early execution of these readiness activities. Preparing staff and systems to meet public company standards well ahead of the IPO process reduces execution risks and strengthens stakeholder trust. Governance also continues to be a vital aspect. The C-suite and board will want to concentrate on strategy and oversight as a newly public entity, rather than dealing with issues related to noncompliance in governance, controls, and risk management that were not properly addressed before the IPO. For companies aligned with ESG trends, there is a significant opportunity to integrate this into their equity story, boosting their appeal to investors and facilitating a successful public listing. And as always, CFOs should keep their eyes on cost discipline and improvement on the path to an IPO. CFOs, leaders, and those in the M&A space may be disheartened that global events appear to have taken the wind out of the deals market just as it emerged from a quiet period – but they shouldn't despair. Times of economic disruption may bring opportunity for those who can cut through the noise and see where the value lies. Ian Turner is Strategy, Risk & Transactions Managing Partner at Deloitte Australia. - Disclaimer This publication contains general information only and Deloitte is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified professional advisor. Deloitte shall not be responsible for any loss sustained by any person who relies on this publication. About Deloitte Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ('DTTL'), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as 'Deloitte Global') does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the 'Deloitte' name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see to learn more about our global network of member firms. Copyright © 2025 Deloitte Development LLC. All rights reserved. -
BBC News
20-02-2025
- Sport
- BBC News
🎧 Saints and Sinners
The latest episode of BBC Radio Solent's Saints and Sinners is available now on BBC Deacon chats with BBC Radio Solent sports editor Adam Blackmore about the latest news from St Mary' team are also joined by former Saints goalkeeper and 1976 FA Cup winner Ian Turner, as well as Brighton fan Stephen Grant to look ahead to the game against the Seagulls this to the full episode on BBC Sounds
